Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-05-15 | HENRI A. TERMEER** (55), Chairman (since 1988), Chief Executive Officer (since 1985) and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc.; Director (since 1992) of AutoImmune, Inc.; Director (since 1993) of Genzyme Transgenics; Director (since 1996) of Diacrin, Inc.; and Trustee (since 1989) of HQH and (since 1992) of HQL. |
| 2002-05-17 | HENRI A. TERMEER** (56), Chairman (since 1988), Chief Executive Officer (since 1985) and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc.; Director (since 1992) of AutoImmune, Inc.; Director (since 1993) of Genzyme Transgenics; Director (since 1996) of Diacrin, Inc.; and Trustee (since 1989) of HQH and (since 1992) of HQL. |
| 2003-05-12 | HENRI A. TERMEER (57), Chairman (since 1988), Chief Executive Officer (since 1985) and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc.; Director (since 1992) of AutoImmune, Inc.; Director (since 1993) of Genzyme Transgenics; Director (since 1996) of Diacrin, Inc.; and Trustee (since 1989) of HQH and (since 1992) of HQL. |
| 2004-05-24 | HENRI A. TERMEER^ (58), GENZYME CORPORATION, 500 KENDALL STREET, CAMBRIDGE, MA 02139 Trustee of HQH (since 1989) and of HQL (since 1992), Chairman (since 1988), Chief Executive Officer (since 1985), and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc. ^ Member of each Fund's Corporate Governance and Nominating Committee. The members of each Fund's Nominating and Governance Committee are Messrs. Lewin and Termeer and Dr. Mack. For the fiscal year ended September 30, 2003, the Independent Trustees as a group received $136,980 from HQH and $134,714 from HQL for fees and reimbursed expenses. The following table sets forth information regarding compensation of Trustees by the Funds for the fiscal year ended September 30, 2003, but does not include expenses. Henri A. Termeer $19,500 from HQH and $19,500 from HQL, total $39,000. |
| 2005-05-10 | HENRI A. TERMEER^~ (59), GENZYME CORPORATION, 500 KENDALL STREET, CAMBRIDGE, MA 02139 Trustee of HQH (since 1989) and of HQL (since 1992); Chairman (since 1988), Chief Executive Officer (since 1985), and President (since 1983) of Genzyme Corporation; ... ^ Member of each Fund's Governance Committee. ~ Member of each Fund's Nominating Committee. ... COMPENSATION TABLE ... Henri A. Termeer $23,500 from each fund, total $47,000. |
| 2006-05-08 | Henri A. Termeer (60), Trustee of HQH (since 1989) and of HQL (since 1992); Chairman (since 1988), CEO (since 1985), and President (since 1983) of Genzyme Corporation... Member of each Fund's Governance Committee, Nominating Committee... Compensation Table: $44,000 total compensation. |
| Filing Date | Source Excerpt |
|---|---|
| 2001-05-15 | Chairman (since 1988), Chief Executive Officer (since 1985) and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc.; Director (since 1992) of AutoImmune, Inc.; Director (since 1993) of Genzyme Transgenics; Director (since 1996) of Diacrin, Inc.; and Trustee (since 1989) of HQH and (since 1992) of HQL. |
| 2002-05-17 | Chairman (since 1988), Chief Executive Officer (since 1985) and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc.; Director (since 1992) of AutoImmune, Inc.; Director (since 1993) of Genzyme Transgenics; Director (since 1996) of Diacrin, Inc.; and Trustee (since 1989) of HQH and (since 1992) of HQL. |
| 2004-05-24 | Chairman (since 1988), Chief Executive Officer (since 1985), and President (since 1983) of Genzyme Corporation (human healthcare products) |
| 2005-05-10 | Chairman (since 1988), Chief Executive Officer (since 1985), and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc. |
| 2006-05-08 | Chairman (since 1988), Chief Executive Officer (since 1985), and President (since 1983) of Genzyme Corporation (human healthcare products); Director (since 1987) of ABIOMED, Inc.; Director (1996-2002) of Diaqirl. |
Data sourced from SEC filings. Last updated: 2025-12-06